Prioritize checking foods that are known potential triggers, including acidic foods like tomatoes or citrus, chocolate, caffeine, coffee, tea, carbonated beverages, fatty or fried foods, spicy foods, and alcohol
Occurred in 8.8% of participants on 9 mg and 20.9% on 12 mg, compared to 0.7% on placebo Dose-dependent (higher dose, higher risk) Generally described as mild Rarely led to discontinuation Why this matters: Dysesthesia was not reported in the Phase 2 trial
Good protein sources include chicken, turkey, fish, eggs, Greek yogurt, cottage cheese, tofu, tempeh, edamame, lentils, chickpeas, and beans
Anticipated Utilization Increases Expanded Eligibility: Coverage for obesity treatment could lead to a 40%60% increase in GLP-1 utilization over the first two years, with an estimated 1.52.5 million additional beneficiaries initiating therapy annually across Medicare and Medicaid
Diarrhea or Constipation : Changes in bowel movements can occur as your body adjusts to the medication
Microdosing tirzepatide helps improve blood sugar control without frequent blood sugar drops